Literature DB >> 34160779

A case of lipoprotein glomerulopathy in a Greek Caucasian male.

S Marinaki1, E Kalaitzakis1, K Kolovou2, H Gakiopoulou3, K Stylianou4, M Papasotiriou5, I N Boletis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34160779     DOI： 10.1007/s11255-021-02930-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  3 in total

1.  Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation.

Authors:  Zhangxue Hu; Songmin Huang; Yu Wu; Yunqiang Liu; Xiaoxia Liu; Dan Su; Ye Tao; Ping Fu; Xiuhui Zhang; Ziying Peng; Sizhong Zhang; Yuan Yang
Journal:  Kidney Int       Date:  2013-09-11       Impact factor: 10.612

2.  A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy.

Authors:  Shan Chen; Zhi-Hong Liu; Jing-Min Zheng; Xin Zhang; Lei-Shi Li
Journal:  J Nephrol       Date:  2007 Sep-Oct       Impact factor: 3.902

3.  Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.

Authors:  Bo Zhang; Zhi-Hong Liu; Cai-Hong Zeng; Jing-Min Zheng; Hui-Ping Chen; Lei-Shi Li
Journal:  J Nephrol       Date:  2008 Jan-Feb       Impact factor: 3.902
  3 in total
  2 in total

1.  Lipoprotein Glomerulopathy, First Case Report from Canada.

Authors:  Julie Anne Ting; Susanna A McRae; Daniel Schwartz; Sean J Barbour; Maziar Riazy
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-06-21

Review 2.  An Updated Review and Meta Analysis of Lipoprotein Glomerulopathy.

Authors:  Meng-Shi Li; Yang Li; Yang Liu; Xu-Jie Zhou; Hong Zhang
Journal:  Front Med (Lausanne)       Date:  2022-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.